Precipio Files Patent for Non-Invasive Cell Capture Device For Gynecological Cancer Detection
March 28, 2018 07:37 ET
|
Precipio, Inc.
In collaboration with Yale, feminine panty liner designed to remove obstacles to early detection NEW HAVEN, Conn., March 28, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc....
Precipio Enters India Liquid Biopsy Market with Adoption by Leading Laboratory
March 26, 2018 07:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostic company Precipio, Inc. (NASDAQ:PRPO), today announced a laboratory services agreement with CORE Diagnostics to offer ICE...
Precipio Restructures Capitalization Table
March 22, 2018 07:37 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), in an 8-K issued today announced an agreement with investors in certain 2017...
Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform
March 20, 2018 07:37 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 20, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has successfully incorporated the use of High Resolution Melt...
Precipio Settles Lawsuit with Crede Capital
March 13, 2018 08:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has settled its lawsuit with Crede Capital Group LLC,...
Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter
February 22, 2018 08:39 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), announced today that within the first half of Q1-2018 it has set up trials for pathology lab services with 4 times...
Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance
February 15, 2018 08:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO) announced today its launch of the first lung cancer treatment resistance panel specifically for the critical...
Precipio Announces Q4 2017 Revenue at 350% of Previous Quarter
February 09, 2018 09:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces preliminary, unaudited revenues for the 4th quarter of 2017 of approximately...
Precipio Enters Japanese Liquid Biopsy Market with First Hospital Sale
February 06, 2018 08:37 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces its entry into the Japanese market with a first order of its ICE-COLD PCR™...
Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania
January 22, 2018 08:27 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO), today announced it is collaborating with the cytogenetics laboratory at the University of...